Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure

Elana J Bernstein; Christian Schmidt-Lauber; Jonathan Kay

doi:10.1016/j.berh.2012.07.008

Nephrogenic systemic fibrosis

Standard

Nephrogenic systemic fibrosis : a systemic fibrosing disease resulting from gadolinium exposure. / Bernstein, Elana J; Schmidt-Lauber, Christian; Kay, Jonathan.

In: BEST PRACT RES CL RH, Vol. 26, No. 4, 08.2012, p. 489-503.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Bernstein, EJ, Schmidt-Lauber, C & Kay, J 2012, 'Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure', BEST PRACT RES CL RH, vol. 26, no. 4, pp. 489-503. https://doi.org/10.1016/j.berh.2012.07.008

APA

Bernstein, E. J., Schmidt-Lauber, C., & Kay, J. (2012). Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure. BEST PRACT RES CL RH, 26(4), 489-503. https://doi.org/10.1016/j.berh.2012.07.008

Vancouver

Bernstein EJ, Schmidt-Lauber C, Kay J. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure. BEST PRACT RES CL RH. 2012 Aug;26(4):489-503. https://doi.org/10.1016/j.berh.2012.07.008

Bibtex

@article{14c5064334954b06973748b8d1eb9cea,

title = "Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure",

abstract = "Nephrogenic systemic fibrosis (NSF) is an iatrogenic fibrosing disorder that primarily affects individuals with chronic kidney disease (CKD) following exposure to gadolinium-based contrast agents (GBCAs) during imaging procedures. NSF is characterised by skin thickening, tethering and hyperpigmentation; flexion contractures of joints; and extracutaneous fibrosis. This article reviews the history, clinical manifestations, epidemiology, histopathology and pathophysiology of this disabling disease.",

keywords = "Contracture/chemically induced, Contrast Media/adverse effects, Diagnosis, Differential, Gadolinium/adverse effects, Humans, Hyperpigmentation/chemically induced, Nephrogenic Fibrosing Dermopathy/chemically induced, Renal Insufficiency, Chronic/complications, Risk Factors, Skin/pathology",

author = "Bernstein, {Elana J} and Christian Schmidt-Lauber and Jonathan Kay",

year = "2012",

month = aug,

doi = "10.1016/j.berh.2012.07.008",

language = "English",

volume = "26",

pages = "489--503",

journal = "BEST PRACT RES CL RH",

issn = "1521-6942",

publisher = "Bailliere Tindall Ltd",

number = "4",

}

RIS

TY - JOUR

T1 - Nephrogenic systemic fibrosis

T2 - a systemic fibrosing disease resulting from gadolinium exposure

AU - Bernstein, Elana J

AU - Schmidt-Lauber, Christian

AU - Kay, Jonathan

PY - 2012/8

Y1 - 2012/8

N2 - Nephrogenic systemic fibrosis (NSF) is an iatrogenic fibrosing disorder that primarily affects individuals with chronic kidney disease (CKD) following exposure to gadolinium-based contrast agents (GBCAs) during imaging procedures. NSF is characterised by skin thickening, tethering and hyperpigmentation; flexion contractures of joints; and extracutaneous fibrosis. This article reviews the history, clinical manifestations, epidemiology, histopathology and pathophysiology of this disabling disease.

AB - Nephrogenic systemic fibrosis (NSF) is an iatrogenic fibrosing disorder that primarily affects individuals with chronic kidney disease (CKD) following exposure to gadolinium-based contrast agents (GBCAs) during imaging procedures. NSF is characterised by skin thickening, tethering and hyperpigmentation; flexion contractures of joints; and extracutaneous fibrosis. This article reviews the history, clinical manifestations, epidemiology, histopathology and pathophysiology of this disabling disease.

KW - Contracture/chemically induced

KW - Contrast Media/adverse effects

KW - Diagnosis, Differential

KW - Gadolinium/adverse effects

KW - Humans

KW - Hyperpigmentation/chemically induced

KW - Nephrogenic Fibrosing Dermopathy/chemically induced

KW - Renal Insufficiency, Chronic/complications

KW - Risk Factors

KW - Skin/pathology

U2 - 10.1016/j.berh.2012.07.008

DO - 10.1016/j.berh.2012.07.008

M3 - SCORING: Review article

C2 - 23040363

VL - 26

SP - 489

EP - 503

JO - BEST PRACT RES CL RH

JF - BEST PRACT RES CL RH

SN - 1521-6942

IS - 4

ER -